Charmaine Lykins
2021
In 2021, Charmaine Lykins earned a total compensation of $488.4K as Chief Commercial Officer at Karuna Therapeutics.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $26,772 |
| Option Awards | $236,939 |
| Salary | $43,181 |
| Other | $81,545 |
| Total | $488,437 |
Lykins received $236.9K in option awards, accounting for 49% of the total pay in 2021.
Lykins also received $100K in bonus, $26.8K in non-equity incentive plan, $43.2K in salary and $81.5K in other compensation.
Rankings
In 2021, Charmaine Lykins' compensation ranked 10,769th out of 12,406 executives tracked by ExecPay. In other words, Lykins earned more than 13.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,769 out of 12,406 | 13th |
Division Manufacturing | 4,744 out of 5,494 | 14th |
Major group Chemicals And Allied Products | 2,132 out of 2,369 | 10th |
Industry group Drugs | 1,894 out of 2,090 | 9th |
Industry Pharmaceutical Preparations | 1,400 out of 1,537 | 9th |
Source: SEC filing on April 27, 2022.
Lykins' colleagues
We found four more compensation records of executives who worked with Charmaine Lykins at Karuna Therapeutics in 2021.